Scientist (Immunology), Vienna
Parallel Bio, Vienna, Vienna, AT
The role
Note to candidates:
Parallel Bio, Vienna, Vienna, AT
Note to candidates:
Parallel Bio is redefining human-first drug discovery. Our platform runs high-throughput immune organoid experiments to accelerate the development of new therapeutics. What makes that valuable is not the engineering of the system itself. It is recognising what these models show that simpler systems cannot, and designing experiments whose outputs connect to decisions in drug development. The most common failure in platform biology is invisible: technically sound experiments that never ask a question only this system could answer.
We are looking for a scientist with a broad immunology background who understands how immune function emerges at the tissue level, who has enough proximity to drug development to recognise translatable evidence, and who designs experiments that produce it. Disease-specific expertise is welcome but not expected. Breadth matters more, since the programme will move across indications as it develops.
This is a hands-on research role with a high degree of independence. The project is one to own end to end: designing and executing the experiments, making the scientific and technical calls that move the work forward, and running several workstreams in parallel. The work is at the bench, running the experiments as well as designing them, with the hands-on element expected to stay constant as the team grows. Note that maintaining cell cultures and experimental continuity requires some weekend work on a rotating basis.
Job Requirements
Vienna, Austria
Your compensation package will include a minimum base salary of €60,000 annually , based on full-time engagement. The final amount will be determined by experience and qualifications. This is a full-time position with no overtime compensation; the agreed salary covers all working hours. Flexible work arrangements may be possible to support work-life balance.
The Mission
Drug discovery has a translation problem: more than 95% of drugs that succeed in animal models fail in humans. We're building the alternative: human-first drug discovery, powered by organoids and AI, running on real human biology from the very first experiment.
Our platform is 87% concordant with clinical patient data - a vast improvement over the 3% translational success rate of animals. We’ve demonstrated the ability to model immunotoxicology, immunogen stimulation, and two autoimmune diseases with more on the way. Numerous pharma partners including 3 Fortune 500 companies are already using the platform. We've raised ~$30M from AIX Ventures, Marc Benioff, Jeff Dean, and Y Combinator. With the FDA Modernization Act 3.0 and the FDA's March 2026 validation framework, the regulatory tailwinds only continue to get stronger.
The opportunity ahead of the company is generational: build the first scaled engine for generating real human biological data, and use it to fundamentally change how medicines are discovered.
Parallel Bio is an equal opportunity employer committed to fostering an inclusive and respectful workplace. We encourage applications from individuals of all backgrounds, regardless of age, gender, ethnicity, religion, disability, or sexual orientation.
€60K / yr
Posted Sep 18, 2026
Parallel BioSan Francisco, CA
$178K–$197K / yr
Posted 24 days ago
Pay not posted
Posted Oct 9, 2026
Latent LabsSan Francisco
Pay not posted
Posted 7 days ago
$120K–$160K / yr
Posted today
Flagship Pioneering, Inc.Cambridge, MA USA +1
$100K–$143K / yr
Posted 2 days ago
Source: the Y Combinator job board. We last checked this job 22 h ago. We first saw it 8 days ago. A job on a job board does not always mean that the team interviews people now.